Ignite Creation Date:
2025-12-24 @ 11:53 AM
Ignite Modification Date:
2026-01-03 @ 8:45 AM
Study NCT ID:
NCT01699061
Status:
COMPLETED
Last Update Posted:
2019-02-12
First Post:
2012-10-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Tivantinib on the QTC Interval in Cancer Subjects
Sponsor:
Daiichi Sankyo
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07
Start Date Type:
None
Primary Completion Date:
2013-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-05
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-01
First Submit QC Date:
None
Study First Post Date:
2012-10-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-08
Last Update Post Date:
2019-02-12
Last Update Post Date Type:
ACTUAL